Condition (MeSH)
Dog Diseases
ClinicalTrials.gov lists 8 trials for Dog Diseases or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
When did Dog Diseases trials start? (8)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 3
- Not applicable
- Observational
Top of scale: 1
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2024 | 1 |
| 2022 | 1 |
| 2018 | 1 |
| 2015 | 1 |
| 2013 | 1 |
| 2011 | 1 |
| 2004 | 1 |
No forecast is made for this condition: it averages 0.6 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 8 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Dog Diseases trials in? (3)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 3 | 1 |
| Not applicable | 2 |
| Observational | 5 |
How many Dog Diseases trials are recruiting? (4)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 2 |
| Completed | 4 |
| Terminated | 1 |
| Unknown status | 1 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which publications cover Dog Diseases? (74)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Systemic mRNA vaccines elicit rapid immune activation in canine brain tumors. | Journal for immunotherapy of cancer | 2025 | Yes |
| Phospholipase A2 inhibitor may shorten the duration of clinical signs in the treatment of neurotoxicity caused by eastern coral snake (Micrurus fulvius) envenomation in 3 dogs. | Journal of the American Veterinary Medical Association | 2025 | Yes |
| Re-emergence of human leishmaniasis in northern Italy, 2004 to 2022: a retrospective analysis. | Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin | 2024 | Yes |
| Progress towards dog-mediated rabies elimination in PR China: a scoping review. | Infectious diseases of poverty | 2023 | Yes |
| MicroRNA as epigenetic regulators of canine cryptorchidism. | Research in veterinary science | 2023 | Yes |
Showing 5 of 74 publications.
Sub-conditions in MeSH (1)
MeSH descendants one level down with at least one trial, most trials first.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: lead sponsors, serious adverse events in this condition's trials, prevalence, and rare-disease identity.
Not computed for conditions with fewer than 10 trials: drugs tested.